MétaCan
Menu
Back to cohort
Record W4412141565 · doi:10.3389/fmed.2025.1593644

Multistakeholder scientific advice for medicinal products used in combination with a medical device or a companion diagnostic in the EU—summary of a Focus group discussion

2025· article· en· W4412141565 on OpenAlexaff
Stiina Aarum, Alexa Hunter, Miha Skvarc, Ilona Reischl, Hilke Zander, J. Zinserling, P van Leeuwen, Jonathan Sutch, Tim Chesworth, Elisabeth Kapeller, Andreas Emmendoerffer, Iordanis Gravanis, Christelle Bouygues, Claudia Vincenzi, Michael Berntgen

Bibliographic record

VenueFrontiers in Medicine · 2025
Typearticle
Languageen
FieldMedicine
TopicScience, Research, and Medicine
Canadian institutions123 Certification (Canada)
Fundersnot available
KeywordsAdvice (programming)Focus groupMedical adviceFocus (optics)MedicineAlternative medicineFamily medicineMedical educationComputer sciencePathologyNursingBusinessMarketing

Abstract

fetched live from OpenAlex

diagnostics (IVDs) and software as a medical device, their development in the EU is proving to be more challenging due to the complexities in working across the regulatory frameworks for medicinal products, medical devices and IVDs. One of the concerns is the lack of a multistakeholder platform [European Medicines Agency (EMA)/Scientific Advice Working Party (SAWP); National Competent Authorities (NCAs) in charge of medicinal products; NCAs for medical devices; notified bodies (NBs)] for scientific and regulatory advice on medicinal products used in combination with medical devices or IVDs [including companion diagnostics (CDx)]. A multistakeholder platform would allow for an opportunity to discuss the scientific expectations of the different decision makers involved and guide the identification of an appropriate development path for both medicine and medical device/IVD (including CDx). In search of a pragmatic approach to facilitate discussions on evidence generation plans, it was agreed in the "9th EMA-Industry stakeholder platform on research and development support" meeting in December 2022 to set up a dedicated Focus group to determine the possibility of provision of scientific advice for medicinal products in combination with a medical device or IVD (including CDx). The Focus group had participants from the EMA SAWP, the NCAs, the NBs, and industry and the EMA. The group explored what kind of scientific questions would benefit from being addressed in comprehensive discussions on evidence generation planning in a multistakeholder setting, and who would be the required decision makers and experts for such multidisciplinary discussions. The discussions covered nine study cases: four were drug-device combinations and five were drug-IVD/CDx combinations. The scope of the discussions excluded stand-alone high-risk medical devices and IVDs for which there was an ongoing scientific advice pilot involving the medical device expert panels. In addition, low-risk stand-alone medical device/IVD developments were also out-of-scope. This article presents the insights of the discussions on the nine study cases reviewed by the Focus group and explores options for next steps to inform future policy and technical discussions on these innovative healthcare developments.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.007
metaresearch head score (Gemma)0.015
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.295
Threshold uncertainty score0.993

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0070.015
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0020.005
Science and technology studies0.0000.002
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.041
GPT teacher head0.339
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueFrontiers in MedicineSame topicScience, Research, and MedicineFrench-language works237,207